Cover Image

Modified Guizhi Shaoyao Zhimu Decoction in the treatment of gout: A systematic review and meta-analysis

Background: Gout is a common joint disease. Currently, although the clinical application of Guizhi Shaoyao Zhimu Decoction (GSZD) for the treatment of gout has a good effect, there is still limited literature focusing on the effectiveness and safety of Guizhi Shaoyao Zhimu Decoction. Purpose: Meta-a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hao Liu (Author), Xiansu Chi (Author), Hongxiu Zhang (Author), Huishan Shi (Author), Jin Pan (Author), Yong Wang (Author), Xiaoyan Xue (Author), Yangting Lu (Author), Xiaobin Song (Author), Ke Ma (Author)
Format:	Book
Published:	Elsevier, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and tolerability of Guizhi-Shaoyao-Zhimu decoction in gout patients: a systematic review and Meta-analysis
by: Qing Zhang, et al.
Published: (2020)

Inducing Apoptosis and Suppressing Inflammatory Reactions in Synovial Fibroblasts are Two Important Ways for Guizhi-Shaoyao-Zhimu Decoction Against Rheumatoid Arthritis
by: Zhang Q, et al.
Published: (2021)

Guizhi-Shaoyao-Zhimu decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF‐κB signalling to suppress osteoclastogenesis
by: Shu-jun Wei, et al.
Published: (2021)

Chinese traditional medicine (GuiZhi-ShaoYao-ZhiMu decoction) as an add-on medication to methotrexate for rheumatoid arthritis: a meta-analysis of randomized clinical trials
by: Chenxi Feng, et al.
Published: (2021)

Chinese herbal medicine for gout: a review of the clinical evidence and pharmacological mechanisms
by: Xiansu Chi, et al.
Published: (2020)

Mechanism of lily bulb and Rehmannia decoction in the treatment of lipopolysaccharide-induced depression-like rats based on metabolomics study and network pharmacology
by: Xiansu Chi, et al.
Published: (2022)

Integrated analysis of the chemical-material basis and molecular mechanisms for the classic herbal formula of Lily Bulb and Rehmannia Decoction in alleviating depression
by: Hongxiu Zhang, et al.
Published: (2021)

Huangqi Guizhi Wuwu Decoction Improves Arthritis and Pathological Damage of Heart and Lung in TNF-Tg Mice
by: Yi Wang, et al.
Published: (2022)

Shaoyao Decoction Inhibits Inflammation and Improves Intestinal Barrier Function in Mice With Dextran Sulfate Sodium-Induced Colitis
by: Honggang Chi, et al.
Published: (2021)

Integrated Metabonomics and Network Pharmacology to Reveal the Action Mechanism Effect of Shaoyao Decoction on Ulcerative Colitis
by: Wu J, et al.
Published: (2022)

Integrated network pharmacology and serum metabolomics approach deciphers the anti-colon cancer mechanisms of Huangqi Guizhi Wuwu Decoction
by: Boyu Pan, et al.
Published: (2022)

Shaoyao Decoction reduced T lymphocyte activation by regulating of intestinal flora and 5-hydroxytryptamine metabolism in ulcerative colitis
by: Jianhua Zhen, et al.
Published: (2024)

The mechanisms of Huangqi Guizhi Wuwu decoction in treating ischaemic stroke based on network pharmacology and experiment verification
by: Weiguo Liao, et al.
Published: (2023)

Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway
by: Lihua Cui, et al.
Published: (2021)

A network pharmacology study on the main active constituents and key pharmacological pathways of Shaoyao Gancao decoction on Osteoarthritis
by: Qiuyue LI, et al.
Published: (2021)

Metabolic profiling and pharmacokinetic studies of Baihu-Guizhi decoction in rats by UFLC-Q-TOF-MS/MS and UHPLC-Q-TRAP-MS/MS
by: Yan He, et al.
Published: (2022)

Chaihu-Guizhi-Ganjiang Decoction is more efficacious in treating irritable bowel syndrome than Dicetel according to metabolomics analysis
by: Mingming Li, et al.
Published: (2022)

Identifying the active components of Baihe-Zhimu decoction that ameliorate depressive disease by an effective integrated strategy: a systemic pharmacokinetics study combined with classical depression model tests
by: Ming Zhong, et al.
Published: (2019)

Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis
by: Zhengwei Zhang, et al.
Published: (2023)

Potential mechanisms of Guizhi decoction against hypertension based on network pharmacology and Dahl salt-sensitive rat model
by: Jiye Chen, et al.
Published: (2021)

Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction
by: Jingwei Li, et al.
Published: (2022)

Shaoyao decoction alleviates TNBS-induced ulcerative colitis by decreasing inflammation and balancing the homeostasis of Th17/Treg cells
by: Dongsheng Wu, et al.
Published: (2023)

Correction to: Identifying the active components of Baihe-Zhimu decoction that ameliorate depressive disease by an effective integrated strategy: a systemic pharmacokinetics study combined with classical depression model tests
by: Ming Zhong, et al.
Published: (2020)

Gut microbiota mediated the therapeutic efficiency of Simiao decoction in the treatment of gout arthritis mice
by: Xiaoying Lin, et al.
Published: (2023)

Gualou Guizhi decoction promotes therapeutic angiogenesis via the miR210/HIF/VEGF pathway in vivo and in vitro
by: Yuqin Zhang, et al.
Published: (2023)

Herbal formula Huangqi Guizhi Wuwu decoction attenuates paclitaxel-related neurotoxicity via inhibition of inflammation and oxidative stress
by: Zhangming Lv, et al.
Published: (2021)

Disease-Modifying Anti-rheumatic Drug Prescription Baihu-Guizhi Decoction Attenuates Rheumatoid Arthritis via Suppressing Toll-Like Receptor 4-mediated NLRP3 Inflammasome Activation
by: Weijie Li, et al.
Published: (2021)

Correction: Gut microbiota mediated the therapeutic efficiency of Simiao decoction in the treatment of gout arthritis mice
by: Xiaoying Lin, et al.
Published: (2023)

Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy
by: Kaijing Yang, et al.
Published: (2024)

Shaoyao Gancao Decoction Ameliorates Paclitaxel-Induced Peripheral Neuropathy via Suppressing TRPV1 and TLR4 Signaling Expression in Rats
by: Chen Y, et al.
Published: (2022)

Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis
by: Chih-Chen Chen, et al.
Published: (2022)

Exploration of the mechanism by which Huangqi Guizhi Wuwu decoction inhibits Lps-induced inflammation by regulating macrophage polarization based on network pharmacology
by: Sutong Wang, et al.
Published: (2023)

Metabolomics Study of Shaoyao Plants Decoction on the Proximal and Distal Colon in Mice with Dextran Sulfate Sodium-Induced Colitis by UPLC-Q-TOF-MS
by: Luo Y, et al.
Published: (2022)

Shaoyao Gancao decoction alleviates paclitaxel-induced cognitive impairment by activating PTEN/PI3K/AKT pathway to inhibit NETs formation
by: Xu Ying, et al.
Published: (2025)

Therapeutic material basis and underling mechanisms of Shaoyao Decoction-exerted alleviation effects of colitis based on GPX4-regulated ferroptosis in epithelial cells
by: Juan Li, et al.
Published: (2022)

Shaoyao-Gancao Decoction Ameliorates the Inflammation State in Polycystic Ovary Syndrome Rats via Remodeling Gut Microbiota and Suppressing the TLR4/NF-κB Pathway
by: Zhuang-peng Chang, et al.
Published: (2021)

Pharmacokinetic Analysis of Huangqi Guizhi Wuwu Decoction on Blood and Brain Tissue in Rats with Normal and Cerebral Ischemia-Reperfusion Injury by Microdialysis with HPLC-MS/MS
by: Zheng HZ, et al.
Published: (2020)

Preliminary Exploration of Clinical Efficacy and Pharmacological Mechanism of Modified Danggui-Shaoyao San in the Treatment of Depression in Patients with Chronic Kidney Disease
by: Xia M, et al.
Published: (2022)

Efficacy and safety of Danggui Niantong Decoction in patients with gout: a systematic review and meta-analysis
by: Sihan Peng, et al.
Published: (2023)

Screening of the key response component groups and mechanism verification of Huangqi-Guizhi-Wuwu-Decoction in treating rheumatoid arthritis based on a novel computational pharmacological model
by: Qinwen Liu, et al.
Published: (2024)